TOPRA conferences & networking events

TOPRA holds several high-level conferences and events annually, including our Annual Symposium in a different European city each year and our Annual Summit in London, to discuss issues of high importance to regulatory affairs professionals.

Download TOPRA's Courses & Conferences calendar for 2024 (PDF)

 

Conferences & special events

Begin DateTitleDescriptionCityCountry
19/10/2026Human Medicines Symposium 2026Join us at the cutting-edge of regulatory affairs at our upcoming Symposium, where industry leaders will explore the latest developments and challenges facing the sector.  Listen to and interact with discussions on the future of regulatory affairs, in the context of an ever-changing landscape from both a regulatory agency and industry perspective. Don’t miss this opportunity to expand your expertise and drive forward-thinking strategies in your organisation.UtrechtNetherlandsHSYMP2026
19/10/2026Veterinary Medicines Symposium 2026The Veterinary Medicines Symposium will concentrate on how we can improve animal health with veterinary medicines by looking at how we collaborate now and in the future, what strategies could be put in place and how we can work together towards new solutions.UtrechtNetherlandsVETSYM2026
20/10/2026Medical Devices/IVDs Symposium 2026The regulation of medical devices is continually changing as more innovative technologies and drug–device combinations are being developed. Anyone involved in medical devices and in vitro diagnostics (IVDs) needs to keep up to date with both the new EU regulations and the clinical requirements. In 2026, the programme will increase to three full days, providing even more opportunities to learn and engage. A dedicated Combination Products stream has also been added, offering fresh insights into this rapidly evolving area.UtrechtNetherlandsMDSYMP2026
20/10/2026Regulatory Updates for Start-ups, SMEs and Academia 2026Small and medium sized companies (SMEs), academia and start-ups face different regulatory challenges when developing the life science products of the future  that meet patients’ needs. This Symposium stream will explore the latest regulatory news, provide updates on recent changes, and highlight the support available for SMEs, academia and start-ups. In 2026, the stream will be extended to 1.5 days, giving you the opportunity to take part in more sessions, join deeper discussions, and make the most of valuable networking time with your fellow conference delegates.UtrechtNetherlandsSME2026

 

TOPRA Special Interest Network (SPIN) events

Start dateTitleDescription
13/11/2025How publishing is changing with eCTD 4.0The Regulatory Operations (RegOps) SPIN Steering Group is pleased to present “How publishing is changing with eCTD 4.0”.  This session has been designed to explore the key changes introduced by the Electronic Common Technical Document (eCTD) 4.0 and provides practical implementation examples, supported by real-world regulatory submission experience.REGOPNOV25

 

TOPRA In regional networking events

Start dateTitleDescriptionCityCountry
04/11/2025Health Economics (HTA) From a Regulatory PerspectiveHealth economics and Health Technology Assessment (HTA) during the development of a new medicine are becoming increasingly important. If a medicine is to reach the patient after regulatory approval, it must undergo health economic evaluation, a basis for pricing and decisions on reimbursement. This takes place at the national level in the different EU countries. Hear from TLV and Industry about the new EU HTA Regulation (EU) 2021/2282 (HTAR) that applies from January 2025 for certain medicines, about Joint Clinical Assessment (JCA) and about HTA strategy during drug development. SwedenSWENOV25
12/11/2025Real-World Evidence in Health Technology DevelopmentTOPRA in Scotland's final meeting of 2025 to be held at the ACD Centre.  Join us, and our expert speakers, as we discuss the role of real-world (RWE) evidence in health technology development. RWE continues to gain prominence as a tool in health technology development with developers and regulators both looking to leverage the insights it can offer to support alternative pathways to market - whether it is through external control arms or post-launch evidence generation - there's a lot to be aware of.  Despite this, the regulatory considerations around RWE are often misunderstood.  Join us and our expert speakers as we look to remove some of these misunderstandings with our expert speakers.EdinburghUnited KingdomSCONOV25